PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 151 filers reported holding PTC THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 1.00 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $910,000 | +39.4% | 19,367 | 0.0% | 0.02% | +41.2% |
Q2 2018 | $653,000 | -92.0% | 19,367 | -93.5% | 0.02% | -92.5% |
Q1 2018 | $8,118,000 | -86.2% | 300,000 | -86.4% | 0.23% | -90.4% |
Q3 2015 | $59,008,000 | +69.7% | 2,210,000 | +229.0% | 2.36% | -19.2% |
Q4 2014 | $34,776,000 | +17.6% | 671,736 | 0.0% | 2.92% | -8.1% |
Q3 2014 | $29,563,000 | +68.4% | 671,736 | 0.0% | 3.17% | +84.2% |
Q2 2014 | $17,559,000 | +0.0% | 671,736 | 0.0% | 1.72% | -6.6% |
Q1 2014 | $17,558,000 | – | 671,736 | – | 1.84% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,750,000 | $84,053,000 | 7.32% |
RTW INVESTMENTS, LP | 3,832,480 | $184,074,000 | 6.94% |
Burrage Capital Management LLC | 195,725 | $9,401,000 | 6.30% |
Asymmetry Capital Management, L.P. | 55,408 | $2,661,000 | 4.77% |
SECTORAL ASSET MANAGEMENT INC | 328,738 | $15,789,000 | 2.36% |
ARMISTICE CAPITAL, LLC | 758,000 | $36,407,000 | 2.10% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 114,000 | $5,470,000 | 1.97% |
Opaleye Management Inc. | 191,000 | $9,174,000 | 1.80% |
Sofinnova Investments, Inc. | 517,092 | $24,836,000 | 1.79% |
Chubb Ltd | 8,180 | $393,000 | 1.68% |